Covid-19 roundup: Biden looks to in­crease ac­cess to Pfiz­er's Paxlovid; House re­quests up­date from FDA on vac­cines for youngest chil­dren

The Biden ad­min­is­tra­tion is look­ing to make Pfiz­er’s Covid-19 pill Paxlovid much more read­i­ly avail­able.

And that will be a key chal­lenge for this ad­min­is­tra­tion, as so far the US has used less than one-third of all Paxlovid cours­es dis­trib­uted to states, and less than one-tenth of the sup­plies the US ini­tial­ly bought last No­vem­ber.

One of the new mea­sures that the ad­min­is­tra­tion is pur­su­ing is a dou­bling of the num­ber of places where the oral an­tivi­rals are avail­able.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER